Novel Microdevices
Hamdi Joda has a diverse work experience in various research and academic roles. Since 2018, Hamdi has been working as the Director of Assay Development at Novel Microdevices. Prior to that, from 2016 to 2018, Hamdi worked as a Postdoctoral Associate at the University of Miami, Miller School of Medicine. From 2015 to 2016, Hamdi served as a Postdoctoral Associate at the University at Albany. Before that, from 2014 to 2015, Hamdi worked as a Postdoctoral Researcher at Universitat Rovira i Virgili - URV. In 2013, Hamdi was a Visiting Scholar at the University at Albany. From 2006 to 2012, Hamdi worked as a Research Assistant at Universitat Rovira i Virgili. In 2010, Hamdi was a Visiting PhD student at Finnish Red Cross.
Hamdi Joda attended the Universitat Rovira i Virgili from 2006 to 2007, where they obtained a Master's Degree in Nanoscience and Nanotechnology. Following this, they pursued higher education and earned a Doctor of Philosophy (Ph.D.) degree from the same institution, with the degree completion occurring between 2008 and 2012. The specific field of study for the Ph.D. is not provided.
This person is not in any teams
Novel Microdevices
Novel Microdevices is a medical device startup that develops a handheld point-of-care medical device to facilitate molecular diagnostics. Its device uses microfluidics to analyze a raw biological sample directly at the point of care and takes only 30 minutes to interpret quality results that enable healthcare professionals to achieve lab-qualityresults in a lab-free environment.The company was founded by Andrea Pais in 2014 and is headquartered in Baltimore, Maryland.